Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Feb 11:9:32.
doi: 10.1186/1749-8090-9-32.

Factors affecting postoperative blood loss in children undergoing cardiac surgery

Affiliations

Factors affecting postoperative blood loss in children undergoing cardiac surgery

David Faraoni et al. J Cardiothorac Surg. .

Abstract

We hypothesized that the influence of cyanotic disease on postoperative blood loss is closely related to age in children undergoing cardiac surgery. Here, we demonstrate that the presence of a cyanotic disease is associated with increased postoperative blood loss in children aged 1 to 6 months. Children with cyanotic disease and aged<1 month who received fresh frozen plasma during cardiopulmonary bypass had less postoperative blood loss and higher maximal clot firmness on FIBTEM than cyanotic children from all other groups. Additional studies are needed to define optimal pathophysiology-based management in children undergoing cardiac surgery.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Blood loss based on age and the presence of cyanotic disease. *p < 0.005 comparing < 1 month and 1-6 months with cyanotic disease (mean difference between groups 7.9% estimated blood volume (EBV), 95% CI 1.4 to 14); ** p < 0.05 comparing 1-6 months and 6-12 months with cyanotic disease (mean difference between groups -6.1% EBV, 95% CI -12 to -0.15); *** p < 0.05 comparing 1-6 months and 1-3 years with cyanotic disease (mean difference between groups -5.6% EBV, 95% CI -11 to -0.12); **** p < 0.005 comparing 1-6 months and > 3 years with cyanotic disease (mean difference between groups -6.9% EBV, 95% CI -13 to -1.3).
Figure 2
Figure 2
Coagulation parameters based on age and the presence of cyanotic disease. (A) Fibrinogen levels measured using the Clauss method at baseline and after cardiopulmonary bypass (CPB) (p < 0.001). (B) Platelet count at baseline and after CPB (p < 0.001). (C) Maximal clot firmness obtained on FIBTEM after CPB. (D) Maximal clot firmness obtained on EXTEM after CPB. ***p < 0.001 comparing < 1 month and all other groups with cyanotic and non-cyanotic diseases, #p < 0.01 comparing < 1 month and all other groups with cyanotic diseases. Blue, cyanotic patients; red, non-cyanotic patients; clear symbols represent baseline tests; and full symbols represent post-CPB tests.

References

    1. Despotis GJ, Gravlee G, Filos K, Levy J. Anticoagulation monitoring during cardiac surgery: a review of current and emerging techniques. Anesthesiology. 1999;9:1122–1151. doi: 10.1097/00000542-199910000-00031. - DOI - PubMed
    1. Guzzetta NA, Miller BE. Principles of hemostasis in children: models and maturation. Paediatr Anaesth. 2011;9:3–9. doi: 10.1111/j.1460-9592.2010.03410.x. - DOI - PubMed
    1. Miller BE, Mochizuki T, Levy JH. et al.Predicting and treating coagulopathies after cardiopulmonary bypass in children. Anesth Analg. 1997;9:1196–1202. - PubMed
    1. Eaton MP, Iannoli EM. Coagulation considerations for infants and children undergoing cardiopulmonary bypass. Paediatr Anaesth. 2011;9:31–42. doi: 10.1111/j.1460-9592.2010.03467.x. - DOI - PubMed
    1. Osthaus WA, Boethig D, Johanning K. et al.Whole blood coagulation measured by modified thrombelastography (ROTEM) is impaired in infants with congenital heart diseases. Blood Coagul Fibrinolysis. 2008;9:220–225. doi: 10.1097/MBC.0b013e3282f54532. - DOI - PubMed

Publication types